Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gentler exercise with a twist: could a tourniquet boost balance in lung disease?

NCT ID NCT07805330

Disease control Sponsor: Rashid Latif Medical College Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 04, 2026 · Last updated Sep 04, 2026

Summary

This trial tests whether blood flow restriction (BFR) rehabilitation, which uses a pressure cuff during low-intensity resistance exercises, can improve functional mobility and balance in people with chronic obstructive pulmonary disease (COPD). Researchers will compare this approach to standard low-intensity resistance training in 50 adults aged 45 to 60. Participants will be randomly assigned to either BFR rehab or control therapy, and their balance, oxygen levels, and heart rate will be measured. The goal is to see if this lighter exercise method can offer benefits without the strain of heavy training.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Blood flow restriction resistance exercise (BFR-RE), which uses a tourniquet cuff to partially restrict blood flow during low-intensity resistance training.
What this could lead to
If effective, this approach could offer a gentler exercise option to help COPD patients improve their mobility and balance, potentially reducing fall risk and enhancing daily function.
What could go wrong
This is a small, early-stage trial, so results may not apply broadly. The use of a tourniquet carries risks like discomfort or bruising, and it may not be suitable for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects who are clinically stable before study * Forced expiratory volume in 1s (FEV1)/forced vital capacity (FVC)\<70% and FEV1 ≥30% but \<80% respectively * Subjects who will be willing to take part in this study Exclusion Criteria: * Upper abdominal surgery * Lung cancer * Open fracture * Mental disorder * Active malignancy * Severe hypertension

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease (COPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic obstructive pulmonary disease (COPD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Arif Memorial Teaching Hospital

    RECRUITING

    Lahore, 54900, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.